RemovedRisk Factors
We compete with system‑affiliated hospitals and healthcare companies, as well as health insurers and private equity companies, in recruiting physicians, acquiring physician practices and, where permitted by law, employing physicians. In 2024,
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
outpatient centers as an extension of their practices. We compete with system‑affiliated hospitals and healthcare companies, as well as health insurers and private equity companies, in recruiting physicians, acquiring physician practices and, where permitted by law, employing physicians.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
There are risks associated with our current and potential future use of artificial intelligence.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
Our hospitals, outpatient centers and related healthcare businesses are subject to an extensive and complex framework of government regulation at the federal, state and local levels. These legal and regulatory standards relate to, among other topics: ownership and operation of facilities and physician practices; licensure, certification and enrollment in government programs; the necessity and adequacy of medical care; quality of medical equipment and services; relationships with and qualifications of physicians and employees; operating conduct, policies and procedures; screening, stabilization and transfer of individuals who have emergency medical conditions; rate‑setting, billing and coding for services; the preparation and filing of cost reports; the handling of overpayments; contractual arrangements; relationships with referral sources and referral recipients; privacy and security; maintenance of adequate records; construction, acquisition, expansion and closure of healthcare facilities or services; environmental protection; compliance with fire prevention and building codes; debt collection; and communications with patients and consumers. In addition, various permits are required to dispense narcotics, operate pharmacies, handle radioactive materials and operate certain equipment. Our facilities are also subject to periodic inspection by governmental and other authorities to determine their compliance with applicable regulations, as well as the standards necessary for licensing and accreditation.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
Our business has been impacted by inflation and its effects on salaries, wages and benefits, as well as other costs. Additional economic factors, including unemployment rates and consumer spending, affect our patient volumes, service mix and revenue mix. Business closings and layoffs in the areas where we operate may lead to increases in the uninsured and underinsured populations and adversely affect demand for our services, as well as the ability of patients to pay for services. Any significant deterioration in the collectability of patient accounts receivable could adversely affect our cash flows, results of operations and liquidity.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
Medical supply prices remain high due to current economic conditions and other factors. In addition, our Ambulatory Care segment continues to be impacted by shipment delays in specialty building systems with respect to its de novo facility development efforts, which are a key part of our portfolio expansion strategy. In fall 2024, a hurricane significantly damaged the North Carolina factory of the largest producer of sterile intravenous fluids in the country, resulting in a national shortage; similar supply shortages in the future could impact our ability to see and treat patients. In general, supply chain operational challenges and cost pressures across our various expense categories may continue or worsen in the future, whether due to geopolitical conflicts, trade tensions, export control rules, tariffs, macro-economic conditions, climate change, weather events or other issues yet to emerge.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
•The requirements in some of our existing joint ventures that one of our wholly owned subsidiaries provide a working capital line of credit to the joint venture could necessitate the allocation of substantial financial resources to the joint venture, potentially impacting our ability to fund our other short‑term obligations.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RewordedRisk Factors
Certain of these provisions are set Such increases have led to expire at the end of 2025; if they are not extended, it could result decreases in significant increases in premiums, potentially leading to decreased enrollment and insurance coverage, and are expected to cause a corresponding rise in the uninsured or a shift of individuals from commercial coverage to government program coverage or other more limited coverage alternatives beginning in 2026.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
There can be no assurance that we will be successful in generating new client relationships or relationships, maintaining existing current relationships on favorable terms. terms, growing service revenues from existing clients, or replacing contracts when they expire or are terminated, which could have a material adverse impact on our results of operations and financial condition.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
The As such, the risk of cyber-attack (including ransomware attack), breach or other disruption to healthcare systems, including ours, remains elevated in the current environment. environment, and the frequency and sophistication of efforts to access or disrupt our systems could continue to increase.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Because most states must operate with balanced budgets, and the Medicaid program is generally a significant portion of a state’s budget, states can be expected to adopt or consider adopting future legislation designed to reduce or not increase reevaluate their Medicaid expenditures. financial plans for 2026 and beyond.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Conversely, if we are unable to successfully maintain, enhance or operate our information systems, including through the implementation of AI AI‑enabled technologies or applications in our operations, we may be, among other things, unable to efficiently adapt to evolving laws and requirements, unable to requirements or remain competitive with others who successfully implement and advance this technology, current and our patients’ safety may be adversely impacted, any of emerging technologies, which could have a material adverse impact on our overall business, financial condition, results of operations or cash flows.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Even in cases where such approvals are obtained, the process of obtaining them could delay the anticipated closing timeline timeline, cause us to incur higher than expected out-of-pocket expenses, and potentially result in significant out‑of‑pocket expenses. conditions or restrictions imposed by applicable authorities.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
There can be no assurance that we will be able to maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on our indebtedness.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
As cybersecurity threats continue to evolve, we may not be able to anticipate certain attack methods methods, including those involving the integration of new or emerging technologies, such as artificial intelligence (“AI”) and Generative AI, in order to implement effective protective measures.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Recent advancements in technology and applications in healthcare, including Generative AI, are enabling our operations healthcare have allowed us to accelerate the adoption of artificial intelligence (“AI”) enabled AI and Generative AI-enabled tools in areas such as clinical care coordination, medical documentation, revenue cycle management and administrative services.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
In years past, we regularly issued We periodically issue new notes to refinance our outstanding notes prior to their maturity, and we may continue this practice in the future. maturity.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Federal government denials or delayed approvals of state waiver applications or extension requests by the states where we operate could also materially impact our Medicaid funding levels. levels, most significantly in those states that have expanded Medicaid.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Moreover, Generative AI systems, which systems that require the collection and processing of sensitive patient data, data could present potential security and privacy risks. risks, as well as risks related to output quality.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
On January 27, 2026, we entered into an agreement with CommonSpirit Health (a successor to Catholic Health Initiatives) (“CHI”) relating to Conifer Health Solutions, LLC (“Conifer”). Subject to the terms of that agreement and other related contracts, the parties have agreed to, among other things: (1) terminate the amended and restated master services agreement pursuant to which Conifer provides end-to-end revenue cycle management services to certain CHI facilities effective as of December 31, 2026; (2) CHI’s payment to us of an aggregate amount equal to $1.900 billion in annual installments over the next three years; provided that, of such amount, $540 million was satisfied on January 27, 2026 by offsetting the $540 million due to CHI from Conifer as described in the next clause; (3) the reduction of our redeemable noncontrolling interest balance, and an increase in our additional paid-in capital balance associated with the redemption by Conifer of CHI’s minority equity interest in Conifer, in exchange for a payment by Conifer of $540 million, which redemption is effective as of January 1, 2026; and (4) the grant of mutual releases to each other in respect of potential disputes related to Conifer.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
The healthcare industry remains subject to significant legislative and regulatory uncertainty. Changes in federal and state healthcare laws, regulations, funding policies or reimbursement practices – especially those involving reductions to government payment rates or access to insurance coverage – could have a material impact on our future revenues and expenses. As discussed in greater detail in the Government Programs section below, the One Big Beautiful Bill Act (“OBBBA”) enacted significant changes to, among other things, the federal tax code and U.S. healthcare policy, coverage and reimbursement systems. While the most consequential healthcare provisions are not scheduled to take effect until 2027 and thereafter, the OBBBA introduces new limitations and eligibility requirements that are expected to materially impact Medicaid funding (including supplemental payments) and enrollment, as well as the health insurance marketplace. The implementation of these requirements is subject to individual state interpretation, and we are unable to predict at this time how states will implement the various requirements of the law. In addition, the OBBBA contained significant changes to the U.S. federal tax code related to the deductibility of depreciation and business interest expense. However, these changes did not have a material impact on our tax expense for the year ended December 31, 2025.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Macroeconomic and Industry Context—The healthcare environment remains influenced by broader macroeconomic and operational factors. Our business has been impacted by inflation and its effects on salaries, wages and benefits, as well as other costs. While general inflation moderated somewhat during 2025, inflation specific to medical supply prices remained high due to current economic conditions and other factors. Furthermore, geopolitical dynamics, trade tensions, tariffs and export control rules may continue to influence pricing and availability within global supply chains. These challenges underscore the importance of operational discipline and adaptive cost management as we navigate the evolving healthcare landscape.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
In September 2025, we opened the newly constructed Florida Coast Medical Center in Port St. Lucie, Florida. This 54‑bed acute care hospital offers specialized services, including advanced cardiac care, diagnostic services, an emergency care department, general surgery, neurosciences, orthopedics, robotics and urology.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Managing Our Capital Structure—In November 2025, we executed a new senior secured revolving credit facility (the “2025 Credit Agreement”) and concurrently terminated our then-existing senior secured revolving credit facility prior to its scheduled maturity date. Also in November, we finalized an amendment of our letter of credit facility. Through these transactions, we increased the borrowing capacity available to us and secured more favorable terms, pricing and reporting requirements.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
•Proceeds from the issuance of $2.250 billion aggregate principal amount of our 2032 Senior Secured First Lien Notes and 2033 Senior Unsecured Notes;
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
•Debt payments of $2.282 billion, including $2.250 billion to fully redeem our February 2027 Senior Secured Second Lien Notes and partially redeem our October 2028 Senior Unsecured Notes;
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
•$198 million of payments to purchase approximately 943 thousand shares of our common stock; and
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Of the eight states in which we operate acute care and specialty hospitals, four have taken action in accordance with the Affordable Care Act to expand their Medicaid programs; however, over half of our licensed beds at December 31, 2025 were located in four states, namely Florida, South Carolina, Tennessee and Texas, that have not expanded Medicaid under the law.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
The impact of the OBBBA is expected to be far‑reaching, with significant implications for states, their healthcare programs and consumers. Key provisions, the most consequential of which are set to take effect beginning in 2027, include new Medicaid work requirements, caps on state-directed payments, limits on provider taxes, stricter eligibility checks, financial incentives for accurate state administration and reforms to federal subsidies.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Once the OBBBA is implemented, the Congressional Budget Office anticipates that millions of individuals could lose health insurance between now and 2034. With respect to Medicaid, these coverage losses may primarily be attributable to policy changes, including the aforementioned work requirements, more frequent eligibility reviews and limits on eligibility. With respect to individuals who purchase Affordable Care Act coverage through state and federal marketplaces, these losses may primarily be attributable to changes in pre-verification requirements and limits to tax credit eligibility. States are awaiting additional guidance from federal agencies on several provisions and are likely to have variation in the details of how they will implement the provisions of the law.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
At this time, we cannot estimate the OBBBA’s impact, nor can we predict the timing of that impact, on our future business, financial condition or results of operations, however, we may experience decreased payments (including supplemental payments) from Medicare, Medicaid and other government programs, as well as delays in the timing of payments to our facilities.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RemovedMD&A
The financial information provided throughout this report, including our Consolidated Financial Statements and the notes thereto, has been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). However, we use certain non‑GAAP financial measures, including Adjusted EBITDA (as defined below), in this report and in communications with investors, analysts, rating agencies, banks and others to assist such parties in understanding the impact of various items on our financial statements. We use this information in our analysis of the performance of our business, excluding items we do not consider relevant to the performance of our operations. In addition, we use these measures to define certain performance targets under our compensation programs.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
“Adjusted EBITDA” is a non‑GAAP measure we define as net income available (loss attributable) to Tenet Healthcare Corporation common shareholders before (1) the cumulative effect of changes in accounting principle, (2) net loss attributable (income available) to noncontrolling interests, (3) income (loss) from discontinued operations, net of tax, (4) income tax benefit (expense), (5) gain (loss) from early extinguishment of debt, (6) other non‑operating income (expense), net, (7) interest expense, (8) litigation and investigation (costs) benefit, net of insurance recoveries, (9) net gains (losses) on sales, consolidation and deconsolidation of facilities, (10) impairment and restructuring charges and acquisition‑related costs, (11) depreciation and amortization, and (12) income (loss) from divested and closed businesses (i.e., health plan businesses). Litigation and investigation costs do not include ordinary course of business malpractice and other litigation and related expense.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
regulations, funding policies or reimbursement practices, especially those involving reductions to government payment rates or access to insurance coverage, could have a significant impact on our future revenues and expenses.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
Staffing and Labor Trends—We compete with other healthcare providers in recruiting and retaining qualified personnel responsible for the operation of our facilities. There is limited availability of experienced medical support personnel nationwide, which drives up the wages and benefits required to recruit and retain employees. In particular, like others in the healthcare industry, we continue to experience shortages of advanced practice providers and critical‑care nurses in certain disciplines and geographic areas. Over the past several years, we have had to rely on higher-cost contract labor, which we compete with other healthcare providers to secure, and pay premiums above standard compensation for essential workers. Our recruitment and retention efforts drove a reduction in contract labor expense during the year ended December 31, 2024 as compared to 2023, such that our contract labor costs are now in line with historical levels.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
We also depend on the general labor pool of available workers in the areas where we operate. In some of our communities, employers across various industries have increased their minimum wage, which has created more competition and, in some cases, higher labor costs for this sector of employees. Furthermore, state‑mandated minimum wage increases in California became effective for healthcare workers in October 2024, with further annual increases anticipated through 2028. The current and expected future increases will result in higher compensation costs for certain of our employees and vendors.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
Economic Conditions and Other Impacts—Our business has been impacted by inflation and its effects on salaries, wages and benefits, as well as other costs. Medical supply prices remain high due to current economic conditions and other factors. In addition, our Ambulatory Care segment continues to be impacted by shipment delays in specialty building systems with respect to its de novo facility development efforts, which are a key part of our portfolio expansion strategy. In general, supply chain operational challenges and cost pressures across our various expense categories may continue or worsen in the future, whether due to geopolitical conflicts, trade tensions, export control rules, tariffs, macro-economic conditions, climate change, weather events or other issues yet to emerge.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
In 2024, we continued to pursue advantageous opportunities to grow our portfolio of hospitals and other healthcare facilities. In July, we opened the newly constructed, 92-bed Westover Hills Baptist Hospital in San Antonio, and, in September, we acquired a majority ownership interest in a 36-bed rehabilitation hospital in El Paso. In addition, we continued construction in 2024 on a new medical campus located in Port St. Lucie, which will include the 54‑bed Florida Coast Surgical Hospital, as well as medical office space. We expect to complete construction of the Port St. Lucie medical campus in late 2025.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
From time to time, we also capitalize on opportunities to refine our portfolio of hospitals and other healthcare facilities when we believe such refinements will help us improve profitability, allocate capital more effectively in areas where we have a stronger presence, deploy proceeds toward higher-return investments across our business, enhance cash flow generation or reduce our debt, among other things. To that end, we divested the SC Hospitals, OCLA CA Hospitals, Central CA Hospitals and AL Hospitals (collectively, the “Divested Hospitals”) in 2024.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
•Repayments of advances received from managed care payers totaling $150 million.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
More specifically, we are also unable to predict the effect of future government healthcare funding policy changes on our business. The Medicare and Medicaid programs are subject to:
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
•statutory and regulatory changes, administrative and judicial rulings, executive orders, interpretations and determinations concerning eligibility requirements, funding levels and the method of calculating reimbursements, among other things;
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
and the sum is multiplied by the fee schedule’s conversion factor (average payment amount) to produce a total payment amount.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RewordedMD&A
At December 31, 2025, our carryforwards available to offset future taxable income consisted of (1) federal net operating loss (“NOL”) carryforwards of approximately $260 $291 million pre‑tax, $139 $140 million of which expires in 2026 to 2037 and $121 $151 million of which has no expiration date, for which the associated deferred tax benefit net of valuation allowance is $2 million; million, (2) capital loss carryforwards of $100 million, for which the deferred tax benefit net of valuation allowance is $23 million, and (3) state NOL carryforwards of approximately $2.937 billion expiring in 2026 through 2045 for which the associated deferred tax benefit, net of valuation allowance and federal tax impact, is approximately $23 million.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Same-Hospital Increase Years Ended December 31, (Decrease) Admissions, Patient Days and Surgeries 2025 2024 2023 Number of hospitals 47 47 — (1) Total admissions 468,250 460,541 439,776 4.7% 1.7% Adjusted admissions 842,992 833,221 813,060 2.5% 1.2% Paying admissions (excludes charity and uninsured) 447,549 439,671 419,929 4.7% 1.8% Charity and uninsured admissions 20,701 20,870 19,847 5.2% (0.8)% Admissions through emergency department 352,964 344,300 330,489 4.2% 2.5% Paying admissions as a percentage of total admissions 95.5 95.6 % 95.5 % —% 0.1% (1) Charity and uninsured admissions as a percentage of total admissions 4.5 4.4 % 4.5 % —% (0.1)% (1) Emergency department admissions as a percentage of total admissions 75.4 % 74.8 % 75.1 % (0.3)% 0.6% (1) Surgeries — inpatient 118,600 118,174 114,346 3.3% 0.4% Surgeries — outpatient 152,375 154,431 156,747 (1.5)% (1.3)% Total surgeries 270,975 272,605 271,093 0.6% (0.6)% Patient days — total 2,283,359 2,297,285 2,236,682 2.7% (0.6)% Adjusted patient days 3,968,902 4,000,871 3,967,259 0.8% (0.8)% Average length of stay (days) 4.88 4.99 5.09 (2.0)% (2.2)% Licensed beds (at end of period) 12,312 12,307 12,324 (0.1)% —% Average licensed beds 12,308 12,326 12,313 0.1% (0.1)% Utilization of licensed beds 50.8 % 50.9 % 49.8 % 1.1% (0.1)% (1)
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Salaries, wages and benefits 46.1 % 24.5 % 47.5 % 25.1 % 49.0 Supplies 14.9 % 25.0 26.6 % Supplies 15.3 15.2 % 26.2 % 15.3 % 27.0 % Other operating expenses, net 23.9 23.3 % 14.8 % 23.8 % 14.3 % 23.9 % 13.7 % Depreciation and amortization 4.2 4.4 % 2.8 % 4.3 % 3.0 % 4.5 % 3.1 % Impairment and restructuring charges, and acquisition-related costs 0.3 % 1.6 % 0.3 % 1.1 % 0.5 % 1.5 % Litigation and investigation costs 0.4 % — % 0.2 % 0.1 % 0.2 % 0.3 % Net gains losses (gains) on sales, consolidation and deconsolidation of facilities (0.1) % 0.3 % (17.4) % (2.5) % — % (0.6) % Operating income 10.7 % 34.4 % 26.2 % 38.2 % 6.8 % 35.6 %
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Number of hospitals (at end of period) 50 49 61 (12) 1 (1) Total admissions 118,472 117,984 136,856 (13.8)% 0.4% Adjusted admissions 214,754 212,777 250,344 (15.0)% 0.9% Paying admissions (excludes charity and uninsured) 112,878 112,466 130,573 (13.9)% 0.4% Charity and uninsured admissions 5,594 5,518 6,283 (12.2)% 1.4% Admissions through emergency department 89,295 87,994 102,041 (13.8)% 1.5% Emergency department visits, outpatient 461,227 460,542 562,929 (18.2)% 0.1% Total emergency department visits 550,522 548,536 664,970 (17.5)% 0.4% Total surgeries 69,503 68,893 86,908 (20.7)% 0.9% Patient days — total 572,884 577,904 692,961 (16.6)% (0.9)% Adjusted patient days 1,000,497 1,006,377 1,217,073 (17.3)% (0.6)% Average length of stay (days) 4.84 4.90 5.06 (3.2)% (1.2)% Average licensed beds 12,492 12,435 15,476 (19.6)% 0.5% Utilization of licensed beds 49.8 % 50.5 % 48.7 % 1.8% (0.7)% (1) Total visits 1,364,976 1,366,394 1,384,105 (1.3)% (0.1)% Paying visits (excludes charity and uninsured) 1,264,324 1,267,881 1,297,846 (2.3)% (0.3)% Charity and uninsured visits 100,652 98,513 86,259 14.2% 2.2% Ambulatory Care:
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Salaries, wages and benefits 7,440 1,265 7,664 1,137 8,182 964 Supplies 2,405 1,375 2,460 1,187 2,545 1,045 Other operating expenses, net 3,759 764 3,842 650 3,984 531 Depreciation and amortization 711 152 684 134 750 120 Impairment and restructuring charges, and acquisition-related costs 48 82 51 51 78 59 Litigation and investigation costs 63 1 30 5 34 13 Net gains losses (gains) on sales, consolidation and deconsolidation of facilities (12) 13 (2,803) (113) — (23) Operating income $ 1,730 $ 1,778 $ 4,223 $ 1,733 $ 1,135 $ 1,375 Net operating revenues 100.0 % 100.0 % 100.0 % 100.0 % Grant income 0.1 % — % 0.1 % — % Equity in earnings of unconsolidated affiliates — % 5.0 % 0.1 % 5.5 % 0.1 % 5.6 % Operating expenses:
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Salaries, wages and benefits 8,705 8,801 9,146 (345) (96) Supplies 3,780 3,647 3,590 57 133 Other operating expenses, net 4,523 4,492 4,515 (23) 31 Depreciation and amortization 863 818 870 (52) 45 Impairment and restructuring charges, and acquisition-related costs 130 102 137 (35) 28 Litigation and investigation costs 64 35 47 (12) 29 Net gains losses (gains) on sales, consolidation and deconsolidation of facilities 1 (2,916) (23) (2,893) 2,917 Operating income $ 3,508 $ 5,956 $ 2,510 $ 3,446 (2,448) Net operating revenues 100.0 % 100.0 % — % Grant income — % 0.1 % (0.1) % Equity in earnings of unconsolidated affiliates 1.2 % 1.3 % 1.1 % 0.2 (0.1) % Operating expenses:
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
During the year ended December 31, 2024, 2025, we acquired controlling ownership interests in 54 27 ASCs and one surgical hospital hospital, and a noncontrolling ownership interest in which one additional ASC; prior to these acquisitions, we did not have a previous investment, increased our ownership interest hold an investment in seven ASCs sufficient to consolidate them and opened 14 de novo ASCs. any of these facilities.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Salaries, wages and benefits 40.8 % 42.6 % 44.5 % (1.9) (1.8) % Supplies 17.7 % 17.6 % 17.5 % 0.1 % Other operating expenses, net 21.2 % 21.7 % 22.0 % (0.3) (0.5) % Depreciation and amortization 4.1 % 4.0 % 4.2 % (0.2) 0.1 % Impairment and restructuring charges, and acquisition-related costs 0.6 % 0.5 % 0.7 % (0.2) 0.1 % Litigation and investigation costs 0.2 0.3 % 0.2 % — 0.1 % Net gains losses (gains) on sales, consolidation and deconsolidation of facilities — % (14.1) % (0.1) % (14.0) 14.1 % Operating income 16.5 % 28.8 % 12.2 (12.3) % 16.6 %
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Certain of these provisions are set Such increases have led to expire at the end of 2025; if they are not extended, it could result decreases in significant increases in premiums, potentially leading to decreased enrollment and insurance coverage, and are expected to cause a corresponding rise in the uninsured or a shift of individuals from commercial coverage to government program coverage or other more limited coverage alternatives beginning in 2026.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
During Restructuring charges during the year ended December 31, 2024, restructuring charges consisted of $17 million of legal costs related to the sale of certain businesses, $12 2025 included $15 million of contract and lease termination fees, $11 million of employee severance costs, $9 $13 million related to the transition of various administrative functions to our Global Business Center (“GBC”) in the Philippines Philippines, $8 million of employee severance costs and $7 $8 million of other restructuring costs.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
The decrease increase of $489 $280 million, or 11.4%, 7.3%, in our Hospital Operations segment’s net operating revenues for the three‑month period in 2024 2025 compared to the same period in 2023 2024 was primarily due to the sales positive impact of a more favorable payer mix, increases in our same-hospital admissions, higher patient acuity, growth in Medicaid supplemental revenue and negotiated commercial rate increases in the Divested Hospitals. 2025 period.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, 2024 Year Ended December 31, 2023 Hospital Operations Ambulatory Care Hospital Operations Ambulatory Care Year Ended December 31, 2025 Year Ended December 31, 2024(1) Net operating revenues $ 16,131 16,138 $ 5,172 $ 16,141 $ 4,534 $ 16,683 $ 3,865 Grant income 10 — 15 1 Equity in earnings of unconsolidated affiliates 6 258 10 250 10 218 Operating expenses:
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new